{{Orphan|date=January 2011}}

'''Frans Van de Werf''' [[Medical doctor|MD]], [[PhD]] and fellow of the [[European Society of Cardiology]] (FESC), the [[American College of Cardiology]] (ACC) and the [[American Heart Association]] (FAHA) is a [[Belgian]] [[cardiologist]] at the [[University Hospital Leuven]] and a [[professor]] of [[medicine]] at the [[Katholieke Universiteit Leuven]]. He is chair of the university hospital's cardiovascular medicine department.<ref>European Perspectives.
[http://circ.ahajournals.org/cgi/reprint/118/12/f67 ''Circulation''. 2008;'''118''':f67-f72], {{doi|10.1161/CIRCULATIONAHA.108.190537}}.</ref>

His research is focused on [[acute coronary syndrome]]s, [[thrombolysis]] and [[antithrombotic]] treatment. His doctoral thesis was an early treatise on the mechanism underlying the [[gallop rhythm]] in [[heart failure]]. Later, he collaborated in [[Leuven]] with [[Désiré Collen]] to discover the clinical application of [[tissue plasminogen activator]] (tPA).

Professor Van de Werf is [[Editor-in-Chief]] of the [[European Heart Journal]] and is a member of the editorial boards of [[Circulation (journal)|''Circulation'']], ''[[International Journal of Cardiology]]'', ''[[Coronary artery disease]]'', ''[[Journal of Thrombosis and Thrombolysis]]''.<ref>[http://www.f1000medicine.com/member/1057354186860998 F1000 profile]. Retrieved 30 March 2009.</ref>

He was awarded the 2005 Joseph Maisin prize for €100000.

==Footnotes==
{{reflist}}

{{Persondata <!-- Metadata: see [[Wikipedia:Persondata]]. -->
| NAME              = Van De Werf, Frans
| ALTERNATIVE NAMES =
| SHORT DESCRIPTION = cardiologist
| DATE OF BIRTH     = unknown
| PLACE OF BIRTH    =
| DATE OF DEATH     =
| PLACE OF DEATH    =
}}{{Use dmy dates|date=March 2011}}
{{DEFAULTSORT:Van De Werf, Frans}}
[[Category:Year of birth missing (living people)]]
[[Category:Living people]]
[[Category:Cardiologists]]
[[Category:Flemish academics]]